Zhonghua yi xue za zhi
-
Zhonghua yi xue za zhi · Aug 2010
Randomized Controlled Trial[Clinical effects of alprostadil injection on acute kidney injury after cardiac surgical procedures].
To explore the clinical effects of alprostadil injection on acute kidney injury (AKI) after cardiac surgical procedures by a prospective randomized controlled trial. ⋯ On the basis of routine therapy, alprostadil injection may promote the recovery of renal function in AKI-patients after cardiac surgical procedures.
-
Zhonghua yi xue za zhi · Aug 2010
Clinical Trial[Ropivacaine volume for ultrasound-guided retrograde infraclavicular brachial plexus block].
The aim of this study was to determine the medium effective volume required to produce an effective retrograde infraclavicular block using an ultrasound (US)-guided technique. ⋯ The appropriate volume of 0.5% ropivacaine required for US-guided retrograde infraclavicular block was 30 ml in clinical practice.
-
Zhonghua yi xue za zhi · Aug 2010
Controlled Clinical Trial[The feasibility of Supreme laryngeal mask airway in gynecological laparoscopy surgery].
To explore the safety, efficacy and side effect of Supreme laryngeal mask airway (LMA) used in gynecological laparoscopy. ⋯ Supreme LMA can provide the same safe and effective ventilation as intubation and less stress response and side effects in gynecological laparoscopy.
-
Zhonghua yi xue za zhi · Aug 2010
Comparative Study Clinical Trial[Concurrent chemoradiotherapy for stage III non-small cell lung cancer].
To evaluate the immediate efficacy and acute toxicity of cisplatin-based induction chemotherapy followed by weekly concomitant chemoradiotherapy and concomitant chemoradiotherapy followed by consolidation chemotherapy in unresectable stage III NSCLC. ⋯ Different chemotherapeutic agents in combination with thoracic radiotherapy are clinically feasible with a moderate toxicity. Their profiles of efficacy and toxicity are comparable to each other.
-
Zhonghua yi xue za zhi · Aug 2010
[Cause and treatment of intracranial hypertension after sylvian cystoperitoneal shunting].
To analyze the cause and treatment of intracranial hypertension after sylvian cystoperitoneal shunting. ⋯ The cause of intracranial hypertension is probably due to tube blockage or less draining after the shrinking or disappearance of arachnoid cyst. Adjusting the location of intracranial tube or performing a lateral ventricle-peritoneal shunt has an excellent efficacy if a dehydration therapy is unresponsive or auto-compensation fails.